|
Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma |
|
View Full Text View/Add Comment Download reader |
|
KeyWord: |
Author Name | Affiliation | Zhi-jian Yu | Digestive Disease Research Section, Affiliated Hospital of Nantong Medical College, 226001, Nantong | Xian-yong Meng | Digestive Disease Research Section, Affiliated Hospital of Nantong Medical College, 226001, Nantong | Ke-cheng Xu | Digestive Disease Research Section, Affiliated Hospital of Nantong Medical College, 226001, Nantong | Zheng-ju Ge | Digestive Disease Research Section, Affiliated Hospital of Nantong Medical College, 226001, Nantong |
|
Hits: 1049 |
Download times: 867 |
Abstract: |
Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin, thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unresectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remission rate of 54.2%, significantly higher than that in embolization with chemotherapeutic agents alone (cisplatin, adriamycin and mitomycin, 32.1%,P<0.01). Morever, the adverse reactions of hydroxycamptothecine and cantharidin, when applied systemically, including hematuria or urodynia were successfully eliminated. |
Close |
|
|
|